Walid Ayoub MD
Hepatology & Liver Transplantation
Clinical Professor of Medicine, Associate Medical Director, Liver Transplant Program, Cedars Sinai Medical Center
Join to View Full Profile
8900 Beverly BlvdSuite 269Los Angeles, CA 90048
Phone+1 310-423-6000
Fax+1 310-423-2356
Dr. Ayoub is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 2004 - 2006
UCLA-VA Greater Los AngelesResidency, Internal Medicine, 1999 - 2002
Creighton University School of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2001 - 2026
NV State Medical License 2011 - 2013
American Board of Internal Medicine Gastroenterology- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Top Doctor 2018-2021
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Clinical Trials
- A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) Start of enrollment: 2020 Dec 18
- Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) Start of enrollment: 2020 Sep 24
Publications & Presentations
PubMed
- Comparative effectiveness of immunotherapy versus lenvatinib in advanced hepatocellular carcinoma: A real-world analysis using target trial emulation.Joseph C Ahn, Wee Han Ng, Yee Hui Yeo, Hyun-Seok Kim, Yun Wang
Hepatology. 2025-03-28 - 4 citationsImpact of the Early COVID-19 Pandemic on Incidence and Outcomes of Hepatocellular Carcinoma in the United States.Jeff Liang, Yi-Te Lee, Yee Hui Yeo, Michael Luu, Walid Ayoub
Clinical and Translational Gastroenterology. 2024-07-01 - 1 citationsDevelopment and validation of a biomarker index for HCC treatment response.Jeff Liang, Po-Yi Li, Joshua Norman, Marie Lauzon, Yee Hui Yeo
Hepatology Communications. 2024-07-01
Journal Articles
- NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications for Liver Transplant and Ethnic and Gender VariancesTsuyoshi Todo, Walid S Ayoub, Naim Alkhouri, Nicholas N Nissen, Vinay Sundaram, Shelly C Lu, Mazen Noureddin, Aarshi Vipani, Tram Tran, Andrew S Klein, Nature
Press Mentions
Ocaliva Poses Enrolment Obstacle in Liver Disease Clinical TrialsFebruary 18th, 2019
Professional Memberships
- Fellow
- Member
- American Association for the Study of Liver DiseasesFellow
Other Languages
- Arabic, French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
